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Zika Virus 
Anne Ambrose-Young, BSN, RN 
     According to the Centers for Disease Control, only an estimated 20% of 
people infected with the Zika virus will ever show symptoms (2016).  The most 
frequently reported symptoms are: 
 
• Fever 
• Rash 
• Conjunctivitis 
• Muscle and joint pain 
• Headache 
 
    The illness usually presents as a mild cold or flu which can last up to a week.  
For this reason, many people do not realize they have been infected and do 
not seek medical treatment.  This makes tracking nearly impossible.   
Conclusion 
     Zika has been in existence for decades, however, the 
pandemic spread and recent links to debilitating neurological 
disorders and devastating birth defects has the scientific 
community racing to control its spread and harm.  Though 
experts now agree that Zika causes microcephaly and GBS, the 
causal link has not been determined.  
 
     In the absence of facts, the public may “fill in the blanks” 
with inaccurate, inappropriate or agenda-driven material.   As 
researchers continue to examine the dangers that Zika may 
present to the public, health care professionals should make a 
concerted effort to stay abreast of the most recent 
developments to properly educate themselves and their 
patients on the present and future implications of this virus. 
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     Because there is no treatment or vaccine for Zika, health care 
providers should focus their attention on education and 
prevention. It is important to understand the risks of traveling to 
Zika affected areas, how to protect yourself and your families, and 
what to do if you suspect you are infected.  
 
*Prevent mosquito bites by wearing long sleeve shirts, use 
effective insect repellent, when outside use barriers such as nets 
and screens.  Stay in air conditioned places when possible – 
mosquitoes hate the cold.  
*Involve the community by organizing clean up campaigns.  
Remove standing water where mosquitos breed and lay their 
eggs.   
*Counsel pregnant women or women of child bearing years on 
the risks and precautions of traveling to areas affected by Zika or 
warm areas where mosquito-borne transmission may occur.    
*Counsel men on the risks of contracting Zika, GBS and possibility 
of transmitting the virus through sexual contact.  Sexually contact 
that results in a pregnancy, or transmission to an already 
pregnant partner, could impact the health of the fetus.      
*Provide information to those already infected with Zika  on how 
to prevent transmission to others, prenatal care, monitor infants 
for developmental milestones and signs of birth defects, and signs 
and symptoms of GBS.   
*Ethical considerations include limiting travel, contraception, 
delayed family planning, and other issues that may be very 
difficult to confront. 
      
     The Zika virus (Zika) was first discovered in 1947 in Uganda, with only 14 cases 
documented before 2007 (Centers for Disease Control and Prevention, 2016).  
Over the last two years, however, this virus, formerly confined to the tropical 
regions of Africa and South East Asia, has been reported in South and Central 
America, Mexico, parts of the Caribbean, Polynesia, with the reports continuing to 
grow.   In February, 2016, the World Health Organization reported that Zika has 
been elevated to a Public Health Emergency of International Concern.    
      
     The spread of Zika is alarming because it has been associated with severe fetal 
brain defects, Guillian-Barre syndrome (GBS)  and encephalopathy.  Transmission 
is primarily through the Aedes aegypti and Aedes albopictus  mosquitos and may 
also be spread by sexual contact.  Further, many of those infected show no signs 
or symptoms, making accidental spread possible.  As of this date, there is no 
vaccine or treatment (CDC, 2016). 
 
     This topic is significant because it underlines the importance of awareness and 
prevention for those that may be at risk of contracting or spreading Zika. It is very 
important that health care workers are educated on the disease process and 
nursing implications of this potentially devastating virus.   
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     Viruses are intracellular parasites that depend on host cells.  The 
structure is a ribonucleic acid (RNA) or deoxyribonucleic acid (DNA), 
with a protective coating.  To fight viral infections, the body will 
release interferons that block intracellular viral replication.  It does 
this by recognizing the antigenic change on an infected cell’s surface.  
However, enveloped viruses release through budding, in which viral 
parts are coated with the healthy cell’s original plasma membrane, 
making recognition much more difficult.   
 
     When a mosquito with Zika bites a human, it injects the virus, 
through its saliva, below the epidermis.  Dermal fibroblasts, 
keratinocytes and immature dendritic cells are all presumed targets of 
the virus and support their replication (Lazear, Stringer & de Silva, 
2016).  Zika appears to promote autophagosome formation to 
replicate, then triggers cell apoptosis to disseminate the virus (Kruger,  
2016).   
      
The Zika virus is: 
 
• Enveloped, icosahedral positive strand RNA virus 
 
• Related to yellow fever, dengue, West Nile, and Japanese 
encephalitis viruses  
 
• Found mainly in the saliva of the Aedes mosquitos 
 
• Is transmitted from mosquito to human, mother to child, through 
sexual contact, blood transfusion and laboratory exposure (CDC, 
2016)  
 
• Zika has also been identified in human saliva, urine and breast 
milk (Malone et a., 2016)  
Significance of Pathophysiology 
     The spread of Zika has increased alarmingly over the past few years.   
 
• Between 1947 and 2007 – 14 cases with no deaths, hospitalizations or 
neurological complications reported. 
• 2007, 49 cases were confirmed on the island of Yap.   
• 2014, 400 cases were reported in French Polynesia with outbreaks in 
Easter Island, the Cook Islands and New Caledonia.  
• Reports now indicate an association with congenital malformations, 
severe neurological and autoimmune complications including 
microcephaly and GBS 
                                       (Pocock & Rezaeian, 2016)
        
    Experts speculate that the rise in communicability and virulence could be 
due to antigenic drift, extreme weather patterns, travel and/or urbanization, 
however, the definitive cause of the emergence remains uncertain.  
     In April, 2016, the CDC announced its position that Zika causes 
microcephaly and other birth defects.  While there is no “smoking gun,” the 
link between Zika and birth defects is partially due to timing - dramatic 
increases in infants born with microcephaly appeared along with dramatic 
increases in confirmed Zika infections.  In addition, Zika has been detected in 
amniotic fluid and tissues of many newborns born with microcephaly and a 
significant proportion of Zika infected women had fetuses that developed birth 
defects including microcephaly (Weaver et al., 2016). 
     The CDC defines microcephaly as a condition where a “…baby’s brain has 
not developed properly during pregnancy or has stopped growing after birth 
which results in a smaller head size” (2016).  Problems with this condition 
include seizures, developmental and intellectual delays, hearing and vision 
problems, feeding problems and difficulty with movement and balance. The 
severity ranges from mild disabilities to death.  
     In addition to birth defects, GBS has also been linked to Zika.  Again, this is 
partially due to timing - a cluster of GBS cases during the French Polynesia Zika 
outbreak in 2013, and increases in GBS in several other countries that were 
experiencing a Zika epidemic (Weaver et al., 2016).  GBS is a rare autoimmune 
disease usually caused by a bacterial or viral infection. It can cause pain, 
weakness or progressive paralysis that moves up the body.  Weakness that 
involves the respiratory muscles may require mechanical ventilator support 
and progression to cardiovascular collapse could be fatal. 
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